GlaxoSmithKline Pharmaceuticals Limited announced that Mr. Sunder Ramachandran - Head of Commercial Excellence, has tendered his resignation effective from the close of business hours on 12th January 2024 to pursue other opportunities outside of the Company. As a result, he will also cease to be a Senior Management Personnel of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,537 INR | +2.09% | +6.70% | +33.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.69% | 5.06B | |
+39.22% | 727B | |
+30.57% | 592B | |
-7.85% | 347B | |
+15.48% | 319B | |
-0.12% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.37% | 160B |
- Stock Market
- Equities
- 500660 Stock
- News GlaxoSmithKline Pharmaceuticals Limited
- GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Sunder Ramachandran as Head of Commercial Excellence, Effective 12 January 2024